The C2 domain of calpain 5 contributes to enzyme activation and membrane localization.

[1]  G. Velez,et al.  Structural Insights into the Unique Activation Mechanisms of a Non-classical Calpain and Its Disease-Causing Variants , 2020, Cell reports.

[2]  M. Baudry.  Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde? , 2019, Current neuropharmacology.

[3]  Danny W. Wilson,et al.  Tripeptide analogues of MG132 as protease inhibitors. , 2019, Bioorganic & medicinal chemistry.

[4]  R. Campbell,et al.  Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide , 2018, The Journal of Biological Chemistry.

[5]  L. Kaderali,et al.  Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB , 2018, PLoS pathogens.

[6]  A. Morris,et al.  Capn5 Expression in the Healthy and Regenerating Zebrafish Retina , 2018, bioRxiv.

[7]  R. Campbell,et al.  Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation , 2018, The Journal of Biological Chemistry.

[8]  A. Geitmann,et al.  A mechanosensitive Ca2+ channel activity is dependent on the developmental regulator DEK1 , 2017, Nature Communications.

[9]  J. Wiśniewski,et al.  Quantitative Analysis of Human Red Blood Cell Proteome. , 2017, Journal of proteome research.

[10]  G. Velez,et al.  Small-angle X-ray scattering of calpain-5 reveals a highly open conformation among calpains. , 2016, Journal of structural biology.

[11]  Daniel G. MacArthur,et al.  The ExAC browser: displaying reference data information from over 60 000 exomes , 2016, bioRxiv.

[12]  Ricardo A. Mata,et al.  The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design , 2016, Science.

[13]  R. Campbell,et al.  Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics. , 2016, Journal of medicinal chemistry.

[14]  G. Velez,et al.  Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses , 2016, Investigative ophthalmology & visual science.

[15]  J. Wiśniewski,et al.  In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. , 2016, Journal of proteomics.

[16]  H. Sorimachi,et al.  An eccentric calpain, CAPN3/p94/calpain-3. , 2016, Biochimie.

[17]  Masanori Watanabe,et al.  The second C2‐domain of copine‐2, copine‐6 and copine‐7 is responsible for their calcium‐dependent membrane association , 2015, The FEBS journal.

[18]  J. Whisstock,et al.  Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes* , 2015, The Journal of Biological Chemistry.

[19]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[20]  A. Bassuk,et al.  Structural Modeling of a Novel CAPN5 Mutation that Causes Uveitis and Neovascular Retinal Detachment , 2015, PloS one.

[21]  R. Campbell,et al.  Allosteric inhibitors of calpains: Reevaluating inhibition by PD150606 and LSEAL. , 2014, Biochimica et biophysica acta.

[22]  J. Bacardit,et al.  The eukaryotic N-end rule pathway: conserved mechanisms and diverse functions. , 2014, Trends in cell biology.

[23]  S. Corbalán-García,et al.  Signaling through C2 domains: more than one lipid target. , 2014, Biochimica et biophysica acta.

[24]  Ranjana Singh,et al.  Calpain 5 Is Highly Expressed in the Central Nervous System (CNS), Carries Dual Nuclear Localization Signals, and Is Associated with Nuclear Promyelocytic Leukemia Protein Bodies* , 2014, The Journal of Biological Chemistry.

[25]  Katherine J. Wert,et al.  Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina. , 2014, Human molecular genetics.

[26]  R. Campbell,et al.  Structure-function relationships in calpains. , 2012, The Biochemical journal.

[27]  V. Sheffield,et al.  Calpain-5 Mutations Cause Autoimmune Uveitis, Retinal Neovascularization, and Photoreceptor Degeneration , 2012, PLoS genetics.

[28]  Jian Peng,et al.  Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.

[29]  H. Sorimachi,et al.  Regulation and physiological roles of the calpain system in muscular disorders , 2012, Cardiovascular research.

[30]  A. Varshavsky.  The N‐end rule pathway and regulation by proteolysis , 2011, Protein science : a publication of the Protein Society.

[31]  L. Aravind,et al.  Identification of novel families and classification of the C2 domain superfamily elucidate the origin and evolution of membrane targeting activities in eukaryotes. , 2010, Gene.

[32]  M. Maki,et al.  Autolytic activity of human calpain 7 is enhanced by ESCRT‐III‐related protein IST1 through MIT–MIM interaction , 2010, The FEBS journal.

[33]  Alan Wells,et al.  m-calpain Activation Is Regulated by Its Membrane Localization and by Its Binding to Phosphatidylinositol 4,5-Bisphosphate* , 2010, The Journal of Biological Chemistry.

[34]  R. Hayes,et al.  Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways , 2009, Apoptosis.

[35]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[36]  Kalle Gehring,et al.  Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains , 2008, Nature.

[37]  R. Campbell,et al.  Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.

[38]  C. Faulkner,et al.  The Phytocalpain Defective Kernel 1 Is a Novel Arabidopsis Growth Regulator Whose Activity Is Regulated by Proteolytic Processing[W] , 2008, The Plant Cell Online.

[39]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[40]  K. Ersfeld,et al.  The calpains: modular designs and functional diversity , 2007, Genome Biology.

[41]  A. Chishti,et al.  Calpain-mediated regulation of platelet signaling pathways , 2007, Current opinion in hematology.

[42]  T. Südhof,et al.  E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2 domains , 2007, Proceedings of the National Academy of Sciences.

[43]  G. Basso,et al.  Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma , 2007, Leukemia.

[44]  F. Fiorino,et al.  A new cell‐permeable calpain inhibitor , 2007, Journal of peptide science : an official publication of the European Peptide Society.

[45]  K. Brandenburg,et al.  Investigations into the membrane interactions of m-calpain domain V. , 2005, Biophysical journal.

[46]  T. Südhof,et al.  Evolutionarily Conserved Multiple C2 Domain Proteins with Two Transmembrane Regions (MCTPs) and Unusual Ca2+ Binding Properties* , 2005, Journal of Biological Chemistry.

[47]  R. Hayes,et al.  Molecular cloning and characterization of rat and human calpain-5. , 2004, Biochemical and biophysical research communications.

[48]  T. Südhof,et al.  C2-Domains in Ca2+-Signaling , 2003 .

[49]  A. Rao,et al.  The Calpain Domain of the Maize DEK1 Protein Contains the Conserved Catalytic Triad and Functions as a Cysteine Proteinase* , 2003, Journal of Biological Chemistry.

[50]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[51]  Z. Jia,et al.  Calpain silencing by a reversible intrinsic mechanism , 2003, Nature Structural Biology.

[52]  S. Bolsover,et al.  Role of the Ca2+/Phosphatidylserine Binding Region of the C2 Domain in the Translocation of Protein Kinase Cα to the Plasma Membrane* , 2003, The Journal of Biological Chemistry.

[53]  Joseph J. Falke,et al.  C2 Domains of Protein Kinase C Isoforms α, β, and γ: Activation Parameters and Calcium Stoichiometries of the Membrane-Bound State , 2002 .

[54]  P. Tompa,et al.  Calpastatin Subdomains A and C Are Activators of Calpain* , 2002, The Journal of Biological Chemistry.

[55]  Z. Jia,et al.  A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.

[56]  T. Südhof,et al.  Three-Dimensional Structure of the Synaptotagmin 1 C2B-Domain Synaptotagmin 1 as a Phospholipid Binding Machine , 2001, Neuron.

[57]  N. Verdaguer,et al.  Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains. , 2001, Journal of molecular biology.

[58]  K. Suzuki,et al.  Domain III of calpain is a ca2+-regulated phospholipid-binding domain. , 2001, Biochemical and biophysical research communications.

[59]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[60]  D. Potter,et al.  Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading* , 1999, The Journal of Biological Chemistry.

[61]  M. Nakao,et al.  Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell – cell contacts , 1999, Oncogene.

[62]  N. Verdaguer,et al.  Ca2+ bridges the C2 membrane‐binding domain of protein kinase Cα directly to phosphatidylserine , 1999 .

[63]  Tomohiko Maehama,et al.  Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.

[64]  S. Corbalán-García,et al.  Determination of the calcium-binding sites of the C2 domain of protein kinase Calpha that are critical for its translocation to the plasma membrane. , 1999, The Biochemical journal.

[65]  M. Medkova,et al.  Mutagenesis of the C2 Domain of Protein Kinase C-α , 1998, The Journal of Biological Chemistry.

[66]  T. Südhof,et al.  C2-domains, Structure and Function of a Universal Ca2+-binding Domain* , 1998, The Journal of Biological Chemistry.

[67]  H. Saya,et al.  Identification of a novel, tissue-specific calpain htra-3; a human homologue of the Caenorhabditis elegans sex determination gene. , 1997, Biochemical and biophysical research communications.

[68]  M. Vingron,et al.  A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. , 1997, Genomics.

[69]  T. Südhof,et al.  The Evolutionary Pressure to Inactivate , 1997, The Journal of Biological Chemistry.

[70]  R. Nixon,et al.  Calpains and calpastatin in SH‐SY5Y neuroblastoma cells during retinoic acid‐induced differentiation and neurite outgrowth: Comparison with the human brain calpain system , 1997, Journal of neuroscience research.

[71]  E. Carafoli,et al.  Calpain: A Cytosolic Proteinase Active at the Membranes , 1997, The Journal of Membrane Biology.

[72]  J. Falke,et al.  The C2 domain calcium‐binding motif: Structural and functional diversity , 1996, Protein science : a publication of the Protein Society.

[73]  P. Tompa,et al.  Autolysis parallels activation of mu-calpain. , 1996, The Biochemical journal.

[74]  K. Wang,et al.  Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. , 1996, Archives of biochemistry and biophysics.

[75]  Hisashi Ito,et al.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. , 1996, Journal of biochemistry.

[76]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[77]  J. Fox.  The Platelet Cytoskeleton , 1993, Thrombosis and Haemostasis.

[78]  N. Brown,et al.  Structural modifications associated with the change in Ca2+ sensitivity on activation of m‐calpain , 1993, FEBS letters.

[79]  T. Zalewska,et al.  Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[80]  C. Slaughter,et al.  Polyclonal antisera specific for the proenzyme form of each calpain. , 1992, Biochimica et biophysica acta.

[81]  G. Demartino,et al.  Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[82]  E. Melloni,et al.  The calpains , 1989, Trends in Neurosciences.

[83]  M. Maki,et al.  Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. , 1989, The Journal of biological chemistry.

[84]  D. E. Goll,et al.  The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain). , 1989, The Journal of biological chemistry.

[85]  H. Kawasaki,et al.  Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function , 1987, FEBS letters.

[86]  B. Horecker,et al.  Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. , 1985, Biochemical and biophysical research communications.

[87]  D. Croall,et al.  Comparison of two calcium-dependent proteinases from bovine heart. , 1984, Biochimica et biophysica acta.

[88]  Y. Ohizumi,et al.  Contraction and increase in tissue calcium content induced by maitotoxin, the most potent known marine toxin, in intestinal smooth muscle , 1983, British journal of pharmacology.

[89]  K. Imahori,et al.  Autolysis of calcium-activated neutral protease of chicken skeletal muscle. , 1981, Journal of biochemistry.

[90]  K. Imahori,et al.  Limited autolysis of Ca2+-activated neutral protease (CANP) changes its sensitivity to Ca2+ ions. , 1981, Journal of biochemistry.

[91]  L S Freedman,et al.  Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.

[92]  E. Krebs,et al.  Activation of skeletal muscle phosphorylase kinase by Ca2+. II. Identification of the kinase activating factor as a proteolytic enzyme. , 1968, Biochemistry.

[93]  R. Hayes,et al.  Potential Use of Calpain Inhibitors as Brain Injury Therapy , 2015 .

[94]  H. Sorimachi,et al.  Calpains: an elaborate proteolytic system. , 2012, Biochimica et biophysica acta.

[95]  I. Assfalg-Machleidt,et al.  μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation , 2006 .

[96]  Barry Honig,et al.  Electrostatic control of the membrane targeting of C2 domains. , 2002, Molecular cell.

[97]  A. Goldberg,et al.  Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.

[98]  Elizabeth M. Smigielski,et al.  dbSNP: a database of single nucleotide polymorphisms , 2000, Nucleic Acids Res..

[99]  G. Guroff,et al.  A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN. , 1964, The Journal of biological chemistry.